utrophin modulators (Summit/Sarepta)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameutrophin modulators (Summit/Sarepta)
Drug Alias Namethird-generation utrophin modulators (Summit Therapeutics/University of Oxford)utrophin modulators (MuOx)utrophin modulators (Summit)utrophin modulators (Summit Therapeutics)SMT-022357
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUtrophin modulators
TargetsUtrophin
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEuropeTurkeyUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMuox Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSarepta Therapeutics IncUniversity Of OxfordSummit Therapeutics Plc
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophy, Duchenne

Other Information

ATC CodeN/A
Related LinksN/A